Aurora Cannabis Price to Book Ratio 2017-2023 | ACB
Historical price to book ratio values for Aurora Cannabis (ACB) over the last 10 years. The current price to book ratio for Aurora Cannabis as of April 17, 2024 is 0.68.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Aurora Cannabis Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-04-17 | 5.79 | 0.67 | |
2023-12-31 | 4.76 | $8.61 | 0.55 |
2023-09-30 | 5.85 | $9.73 | 0.60 |
2023-06-30 | 5.35 | $10.31 | 0.52 |
2022-12-31 | 9.23 | $12.87 | 0.72 |
2022-09-30 | 12.20 | $15.16 | 0.80 |
2022-03-31 | 40.00 | $38.37 | 1.04 |
2021-12-31 | 54.10 | $78.19 | 0.69 |
2021-09-30 | 69.20 | $81.19 | 0.85 |
2021-03-31 | 93.10 | $86.89 | 1.07 |
2020-12-31 | 83.10 | $91.64 | 0.91 |
2020-09-30 | 46.50 | $121.21 | 0.38 |
2019-12-31 | 259.20 | $297.70 | 0.87 |
2019-09-30 | 526.80 | $394.82 | 1.33 |
2019-03-31 | 1087.20 | $391.01 | 2.78 |
2018-12-31 | 595.20 | $391.06 | 1.52 |
2020-03-31 | 108.71 | $265.63 | 0.41 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.322B | $0.175B |
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $189.499B | 24.60 |
Stryker (SYK) | United States | $128.469B | 31.85 |
Medtronic (MDT) | Ireland | $105.230B | 14.90 |
Boston Scientific (BSX) | United States | $99.939B | 33.23 |
EssilorLuxottica (ESLOY) | France | $98.203B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.924B | 0.00 |
Haleon (HLN) | United Kingdom | $36.986B | 28.93 |
ResMed (RMD) | United States | $27.191B | 27.18 |
Terumo (TRUMY) | Japan | $25.327B | 35.77 |
Zimmer Biomet Holdings (ZBH) | United States | $25.081B | 16.15 |
Baxter (BAX) | United States | $20.095B | 14.66 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Insulet (PODD) | United States | $12.094B | 63.50 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.404B | 0.00 |
Demant (WILYY) | Denmark | $10.151B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.349B | 24.87 |
BellRing Brands (BRBR) | United States | $7.231B | 38.88 |
Haemonetics (HAE) | United States | $4.275B | 21.86 |
Lantheus Holdings (LNTH) | United States | $4.232B | 10.93 |
Perrigo (PRGO) | Ireland | $4.060B | 11.61 |
GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
Envista Holdings (NVST) | United States | $3.399B | 12.93 |
Prestige Consumer Healthcare (PBH) | United States | $3.379B | 15.98 |
QuidelOrtho (QDEL) | United States | $2.695B | 9.78 |
Neogen (NEOG) | United States | $2.634B | 25.33 |
Green Thumb Industries (GTBIF) | United States | $2.613B | 82.80 |
ICU Medical (ICUI) | United States | $2.347B | 17.51 |
TG Therapeutics (TGTX) | United States | $2.162B | 700.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.046B | 0.00 |
Owens & Minor (OMI) | United States | $1.903B | 18.27 |
Verano Holdings (VRNOF) | United States | $1.686B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.618B | 0.00 |
InMode (INMD) | Israel | $1.480B | 7.66 |
National Vision Holdings (EYE) | United States | $1.479B | 46.05 |
LeMaitre Vascular (LMAT) | United States | $1.430B | 47.50 |
AdaptHealth (AHCO) | United States | $1.277B | 9.61 |
Warby Parker (WRBY) | United States | $1.241B | 0.00 |
AtriCure (ATRC) | United States | $1.117B | 0.00 |
MacroGenics (MGNX) | United States | $1.044B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.725B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
Evolus (EOLS) | United States | $0.698B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.698B | 15.07 |
Jin Medical (ZJYL) | China | $0.673B | 0.00 |
Canopy Growth (CGC) | Canada | $0.610B | 0.00 |
Quanterix (QTRX) | United States | $0.610B | 0.00 |
Valneva SE (VALN) | France | $0.556B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.526B | 11.40 |
TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
PetIQ (PETQ) | United States | $0.477B | 17.80 |
ZimVie (ZIMV) | United States | $0.427B | 26.15 |
Biote (BTMD) | United States | $0.426B | 4.05 |
OraSure Technologies (OSUR) | United States | $0.399B | 6.61 |
Zynex (ZYXI) | United States | $0.391B | 45.00 |
Surmodics (SRDX) | United States | $0.379B | 40.92 |
Viemed Healthcare (VMD) | United States | $0.320B | 31.77 |
Cerus (CERS) | United States | $0.305B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.253B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.244B | 14.91 |
Omeros (OMER) | United States | $0.199B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.195B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.187B | 0.00 |
Veru (VERU) | United States | $0.184B | 0.00 |
High Tide (HITI) | Canada | $0.177B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
FitLife Brands (FTLF) | United States | $0.132B | 21.19 |
Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.125B | 62.70 |
Allurion Technologies (ALUR) | United States | $0.113B | 0.00 |
InterCure (INCR) | Israel | $0.108B | 18.23 |
Cellectar Biosciences (CLRB) | United States | $0.107B | 0.00 |
Fonar (FONR) | United States | $0.106B | 9.12 |
Safety Shot (SHOT) | United States | $0.102B | 0.00 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
Brainsway (BWAY) | Israel | $0.085B | 0.00 |
Chimerix (CMRX) | United States | $0.082B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.072B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.97 |
Apyx Medical (APYX) | United States | $0.048B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.041B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.91 |
Modular Medical (MODD) | United States | $0.034B | 0.00 |
Exagen (XGN) | United States | $0.025B | 0.00 |
Nephros (NEPH) | United States | $0.021B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.018B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.36 |
ProSomnus (OSA) | United States | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |